Skip to main content
logo
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2352
-0.0048 (-2.00%)
Jul 17, 2026, 9:59 AM EDT - Market open

Vistagen Therapeutics Revenue

In the fiscal year ending March 31, 2026, Vistagen Therapeutics had annual revenue of $1.27M with 161.11% growth. Vistagen Therapeutics had revenue of $465.00K in the quarter ending March 31, 2026.

Revenue (ttm)
$1.27M
Revenue Growth
+161.11%
P/S Ratio
7.76
Revenue / Employee
$30,951
Employees
41
Market Cap
9.65M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.27M783.00K161.11%
Mar 31, 2025486.00K-578.00K-54.32%
Mar 31, 20241.06M1.29M-
Mar 31, 2023-227.00K-1.34M-
Mar 31, 20221.11M19.40K1.78%
Mar 31, 20211.09M--
Mar 31, 2020---
Mar 31, 2019---
Mar 31, 2018---
Mar 31, 20171.25M--
Mar 31, 2016---
Mar 31, 2015---
Mar 31, 2014---
Mar 31, 2013200.40K-1.14M-85.07%
Mar 31, 20121.34M-728.80K-35.19%
Mar 31, 20112.07M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Curis7.06M
Immuron4.99M
Traws Pharma2.73M
Exicure500.00K
BioRestorative Therapies357.87K
Kiora Pharmaceuticals20.00K
BioCardia3.00K
Revenue Rankings

VTGN News

More News